Milestone Scientific (MLSS) Common Equity (2010 - 2026)

Milestone Scientific's Common Equity history runs 17 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Common Equity fell 48.8% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (down 48.8% YoY), while the FY2025 annual figure was $2.8 million, down 51.78% from the prior year.
• Common Equity came in at $2.3 million for Q1 2026 at Milestone Scientific, down from $2.8 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $14.8 million in Q1 2022 to a low of $2.3 million in Q1 2026.
• A 5-year average of $7.3 million and a median of $7.5 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity advanced 3.27% in 2024 and tumbled 64.7% in 2025, its largest moves.
• Milestone Scientific's Common Equity stood at $10.0 million in 2022, then declined by 19.93% to $8.0 million in 2023, then fell by 27.21% to $5.8 million in 2024, then plunged by 51.78% to $2.8 million in 2025, then slipped by 18.76% to $2.3 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $2.3 million, $2.8 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison